Biohaven is powering ahead with its bold ambition to sharply reduce R&D spending—even as analysts warn the company will need to be even stricter with its expenditures. | Biohaven is powering ahead ...

George is a professor of genetics at Harvard Medical School and professor of health sciences and technology at Harvard and MIT. He is a prolific researcher studying genetic sequencing, genome editing, ...

Anthropic CEO Dario Amodei says artificial intelligence could trigger a biotech renaissance, accelerating breakthroughs in peptide drugs, CAR-T therapies, and programmable biology through AI-assisted ...

In an effort to battle against what members feel is an existential threat to their business, a group of 10 domestic biotech companies have launched the Midsized Biotech Alliance of America with a ...

Microsoft has backed out of building data centers, Intel's factory opening has been delayed to 2030, but one tech industry is going strong in central Ohio: Biotechnology. The now multibillion dollar ...

So, what will the early months of 2026 look like for the biotech sector? First, let me say that the biotech sector being 'en fuego' over the past three quarters has made my year as far as my portfolio ...

Forbes contributors publish independent expert analyses and insights. I write about finance, innovation, climate and sustainability Europe’s next wave of biotech innovation could determine how the ...

Biotechnology has emerged as a fundamental solution for addressing the multidimensional challenges of food security in Nigeria. Experts told the News Agency of Nigeria (NAN) on Wednesday in Abuja that ...

We take a look at Oxford’s biotech and life sciences hub to discover what makes this historical city a hotspot for scientific innovation.